Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Journal (Sudbury, Mass.)|November 6, 2001
Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridizationH L Liu, R Gandour-Edwards, P N Lara, et al.Prostate Cancer and Prostatic Diseases|May 2, 2007
Inhibition of Akt pathways in the treatment of prostate cancerE C Nelson, C P Evans, P C Mack, et al.Prostate Cancer and Prostatic Diseases|November 1, 2006
Clinical implications of neuroendocrine differentiation in prostate cancerE C Nelson, A J Cambio, J C Yang, et al.Clinical Pharmacology and Therapeutics|February 14, 2015
Innovative Clinical Trials: The LUNG-MAP StudyC E Steuer, V Papadimitrakopoulou, R S Herbst, et al.Prostate Cancer and Prostatic Diseases|February 11, 2015
Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patientsE N Lo, L A Beckett, C X Pan, et al.Investigational New Drugs|July 30, 1999
Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124)F J Meyers, D Lew, P N Lara, et al.Oncogene|March 26, 2014
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelH G Nguyen, J C Yang, H-J Kung, et al.Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancerR T O'Donnell, S J DeNardo, A Yuan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollmentP N Lara, R Higdon, N Lim, et al.Pageof 3